Greykasell Wealth Strategies »

Vertex Pharmaceuticals Incorporated shares owned by Greykasell Wealth Strategies

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Greykasell Wealth Strategies from 13F filings

Historical chart of Greykasell Wealth Strategies investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Greykasell Wealth Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Greykasell Wealth Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.5k 9 391.67

More positions owned by Greykasell Wealth Strategies

Ishares Global 100 Etf Etf (IOO)
Apple Stock (AAPL)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Spdr Gold Shares Etf (GLD)
Fidelity Total Bond Etf Etf (FBND)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Ishares Core S&p 500 Etf Etf (IVV)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Wisdomtree International Hedged Quality Dividend Growth Fund Etf (IHDG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Nvidia Corporation Stock (NVDA)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Core S&p Small Cap Etf Etf (IJR)

View all positions for Greykasell Wealth Strategies

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated